1-3 of 3
Robert Wilkinson
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Incidence of Infections Associated with the Use of Bispecific Antibodies in B-Cell Non-Hodgkin Lymphomas

Amneh A Fares, Diana Martinez, Saba Musleh Ud Din, Robert Wilkinson, Julio C Chavez, Fernando Manuel Vargas Madueno, Jose Sandoval-Sus
Journal: Blood
Blood (2023) 142 (Supplement 1): 2329.
https://doi.org/10.1182/blood-2023-174415
Published: 2023
Journal Articles

Safety and Efficacy of Midostaurin in Combination with High-Dose Daunorubicin in 7+3 Induction for Acute Myeloid Leukemia with FLT3 Mutation

Yehuda E. Deutsch, MD, Robert Wilkinson, PharmD, Amanda Brahim, PharmD, Stephanie Boisclair, MD, Jose Sandoval-Sus, MD, Annie Kuehnel, APRN, Terrence J Bradley, MD, Chetasi Talati, MD, Ellen Madarang, PharmD, Jillian Lykon, PharmD, Justin M. Watts, MD, David A Sallman, MD, Kendra L. Sweet, MD, Jeffrey E. Lancet, MD, Hugo F. Fernandez, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3896.
https://doi.org/10.1182/blood-2019-129331
Published: 2019
Journal Articles

The Specific Aurora Kinase Inhibitor AZD1152 Significantly Affects the Growth of Human Leukaemic Cells in an In Vivo AML Model.

Daniel Pearce, Rajesh Odedra, Robert Wilkinson, Dominique Bonnet
Journal: Blood
Blood (2006) 108 (11): 162.
https://doi.org/10.1182/blood.V108.11.162.162
Published: 2006